Loading...

LIVN LIVANOVA PLC Legal Disputes 8-K Filing

LVNV

LVN

LIVANOVA PLC

(LIVN)

2024 8-K

Quarterly Financial Update

Board Appointment

Financial Statements

Civil litigation

Financial Statements

Legal Liability Update

Financial Results

Regulatory Update

Financial Results

Director Appointment

Management Departure

AGM Approval of Amendments ...

Financial Results Announcement

Proposed Convertible Notes ...

Appointment of CEO

Restructuring Plan Approval

Cybersecurity Incident Update

Update on Operations

Cybersecurity Incident

Extension of Interim CEO Te...

Appointment and Retirement ...

Retirement of Marco Dolci

AGM Approval of Incentive A...

Appointment of CEO

Results of Operations, Depa...

Update on RECOVER Depressio...

Financial Results and Amend...

Regulation FD Disclosure

Regulation FD Disclosure

External Links:

LivaNova PLC expresses disappointment over CMS maintaining VNS Therapy for drug-resistant epilepsy at a specific payment classification but believes it won't impact the business and will continue to seek reimbursement opportunities.

AI Assistant

LIVANOVA PLC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.